TGTX icon

TG Therapeutics

244 hedge funds and large institutions have $2.19B invested in TG Therapeutics in 2023 Q2 according to their latest regulatory filings, with 61 funds opening new positions, 73 increasing their positions, 72 reducing their positions, and 30 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more capital invested

Capital invested by funds: $ → $

more call options, than puts

Call options by funds: $ | Put options by funds: $

more funds holding

Funds holding:

1% more repeat investments, than reductions

Existing positions increased: 73 | Existing positions reduced: 72

5.65% less ownership

Funds ownership: 64.81%59.17% (-5.6%)

25% less funds holding in top 10

Funds holding in top 10: 43 (-1)

Holders
244
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$144M
Puts
$97.6M
Net Calls
Net Calls Change

Top Buyers

1 +$40.4M
2 +$26.5M
3 +$22.3M
4
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$18.4M
5
Man Group
Man Group
United Kingdom
+$17.1M
Name Holding Trade Value Shares
Change
Change in
Stake
126
$778K
127
$777K
128
$766K
129
$691K
130
$690K
131
$676K
132
$673K
133
$673K
134
$659K
135
$621K
136
$621K
137
$604K
138
$586K
139
$567K
140
$556K
141
$554K
142
$554K
143
$534K
144
$534K
145
$524K
146
$518K
147
$515K
148
$508K
149
$463K
150
$461K